Quick Answer
Evommune, Inc. reported Shares Outstanding of 31.52 million shares for fiscal year 2025.
Evommune, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 31.52M | +1932.0% |
| 2024 | 1.55M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.55M | — | +0.2% |
| December 31, 2024 | 1.55M | — | — |
- Evommune, Inc. showed an increase of +1932.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2024–2025 period, Evommune, Inc.’s shares outstanding has grown by 1932.0% (from 1.55 million shares to 31.52 million shares).
- The most recent figure is from Evommune, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: